PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital Fudan University, Shanghai 200032, China.\', \'School of Pharmacy, University of Wyoming College of Health Sciences, Laramie, WY 82071 USA.\', \'Department of Emergency, Shanghai Tenth People\'s Hospital, Tongji University School of Medicine, Shanghai 200072, China.\', \'University of Wyoming at Casper and the Department of Zoology and Physiology, Casper, WY 82601, USA.\', \'Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital Fudan University, Shanghai 200032, China; School of Pharmacy, University of Wyoming College of Health Sciences, Laramie, WY 82071 USA; Department of Pathology, University of Washington Seattle, Seattle, WA, USA. Electronic address: ren.jun@zs-hospital.sh.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-2952(20)30350-610.1016/j.bcp.2020.114114
?:doi
?:hasPublicationType
?:journal
  • Biochemical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32579957
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.832
?:rankingScore_hIndex
  • 177
?:title
  • SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all